Caligenix

What Caligenix does

Caligenix is a Los Angeles-based precision-health biotech founded in 2017 that has built a first-of-its-kind combined DNA and RNA biomarker test backed by a fully automated robotics lab and an AI-powered recommendation engine. The platform analyzes millions of DNA and RNA data points to derive "biomarker rules" that map individual genomic profiles to specific nutrition, supplement, skincare, and (per a third sub-brand) immune-health interventions, a methodology the company calls Diagnostic Biology. Its proprietary GeneLoop technology adds a continuous biofeedback loop intended to measure intervention efficacy — something the company positions as missing from the broader wellness industry.

Caligenix monetizes through a dual model. Direct-to-consumer, it sells subscription-based personalized recommendations under sub-brands Biotype (nutrition and supplements via getbiotype.com), Dermatype (skincare using genomic biomarkers plus facial scans via dermatype.com), and Immunotype (immune health via getimmunotype.com). B2B, it offers white-label licensing of its testing technology, AI recommendation engine, and GeneLoop feedback loop to wellness product brands that lack efficacy evidence and personalization capability. Pricing is not publicly disclosed and the company directs interested customers to contact forms for more detail.

The company is privately held, founder-led (Dr. Tzur Gabi and Eliad Josephson as co-founders, Dr. Steve Henig as CSO, Mitch Harhay as CTO), with a scientific advisory board spanning molecular nutrition, biochemistry, and functional medicine. It operates with 11-50 employees from a single headquarters in Los Angeles, has raised $720,000 in a single May 2020 round, and has not disclosed customers, revenue, patents, awards, or regulatory actions.

Name

Caligenix

Legal name

Caligenix Inc.

Website

https://caligenix.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Caligenix is a Los Angeles-based precision-health biotech that uses a proprietary combined DNA and RNA biomarker test with AI to deliver personalized nutrition, supplement, skincare, and immune-health recommendations to individual consumers via sub-brands Biotype, Dermatype, and Immunotype, and licenses the platform B2B to wellness brands.

Ownership category

akta.pro rank

Product category

Precision Health / Genomic Wellness Platform

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Proteomics & Biomarker Analytical Testing (HLAGADAG)

akta.pro secondary industry

Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL)

Keywords

• Genomic biomarker testing
• Personalized wellness platform
• DNA RNA analysis
• AI nutrition recommendations
• Skincare genomic testing

Headquarters

HQ city

Los Angeles

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Biotype Nutrition Platform: Subscription-based genomic biomarker testing and ongoing nutrition/supplement recommendations sold to individual consumers and wellness brands. The AI analyzes biomarkers to determine optimal nutrition and supplement intervention for each individual.
2. Dermatype Skincare Platform: Genomic biomarker testing combined with facial scans to determine optimal skincare interventions and recommend proprietary skincare products. Sold directly to consumers through e-commerce.
3. B2B Genomic Technology Licensing: Licensing of proprietary testing technology, AI recommendations, and GeneLoop feedback loop to wellness product brands to improve customer health outcomes and product efficacy evidence.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Caligenix is a precision health biotech company that combines DNA and RNA biomarker testing with AI/ML to deliver personalized nutrition, skincare, and immunity recommendations to individual consumers through its sub-brands (Biotype, Dermatype, Immunotype). The company also licenses its underlying genomic technology and AI recommendation platform to other wellness brands on a B2B basis.

Product overview

Caligenix is a precision health biotech company offering a platform of genomic personalization products. The core offering is the DNA + RNA Biomarker Test, which analyzes genetic data to power personalized recommendations. This platform supports two primary consumer-facing sub-brands: Biotype (nutrition and supplementation recommendations) and Dermatype (skincare recommendations using facial scans). The company also offers GeneLoop, a proprietary feedback loop technology that enables real-time biofeedback and continuous personalization. The architecture combines a globally recognized robotics lab for DNA/RNA processing with AI to generate personalized recommendations at scale, moving from population-level data (n=10,000) to individual personalization (n=1).

Differentiator

Problem solved

Functional benefit

Brands

• Biotype: Genomic bio-markers analyzed by AI technology that determines the optimal nutrition and supplement intervention for each individual.
• Dermatype

Products and services

• Biotype

Quantifiable outcome

• Moving from population-level personalization (n=10,000) to individual-level (n=1) recommendations

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Care/of (Bayer): Care/of is a personalized vitamin/supplement subscription brand (owned by Bayer) that uses a short quiz — not genomic data — to match products to individuals. It is comparable as a personalized wellness product competitor downstream of Caligenix's Biotype but bypasses biomarker testing as the input layer.
• Thorne HealthTech: Thorne is a large personalized supplement and wellness brand with proprietary testing tie-ins and B2B partnerships with practitioners. It is comparable as a downstream brand competitor/partner for Caligenix, since Caligenix's B2B licensing model specifically targets the kind of premium wellness brands that sit in Thorne's category.
• 23andMe: 23andMe is the most established consumer DNA-testing brand, offering genetic reports and a therapeutics business. It covers genetic testing for wellness at population scale but does not focus on RNA expression, real-time feedback, or personalized product recommendations to the same depth as Caligenix.
• Helix: Helix operates a DNA-sequencing platform-as-a-service that partners with consumer brands to deliver DNA-powered products (e.g., nutrition, ancestry, health). It is the closest analog to Caligenix's B2B 'genomic technology licensing' motion, where brands embed a testing/insight layer without building the lab themselves.

Direct peers

• Viome Life Sciences: Viome sells RNA-based gene-expression testing (gut microbiome and cellular) feeding AI-driven personalized nutrition and supplement recommendations via subscription. Direct comparison: Viome is the most analogous business to Caligenix's DNA+RNA biomarker testing feeding personalized supplements/skincare recommendations, with a similar D2C + B2B emphasis.
• Orig3n: Orig3n sells consumer DNA tests focused on wellness, nutrition, fitness, and skincare traits through a D2C subscription model. It overlaps directly with Caligenix's biomarker-led personalization for nutrition/skincare while being slightly narrower on the molecular input (DNA only).
• InsideTracker: InsideTracker delivers personalized nutrition and wellness plans driven by blood biomarkers and (newer) DNA inputs. It is comparable to Caligenix because both sit at the intersection of biomarker data, AI-driven recommendations, and direct-to-consumer subscriptions, though InsideTracker's core data layer is blood rather than DNA+RNA.
• SkinDNA Genetic Test: SkinDNA provides DNA-based genetic testing marketed specifically for personalized skincare product selection. It competes head-to-head with Caligenix's Dermatype sub-brand: same input (genetic markers), same use case (skincare product recommendation), same D2C delivery mechanism.
• Atlas Biomed Group: Atlas Biomed offers DNA + microbiome testing for personalized nutrition and health recommendations in a D2C subscription model. It is directly comparable to Caligenix's Biotype/Dermatype-as-a-service approach (multi-omic input feeding personalized wellness output) and competes in the same consumer segment.

Emerging players

• Habit (Habititud): Habit was a personalized nutrition company using DNA + blood-based biomarkers + habits to recommend foods and supplements, sold D2C. Its scope (personalized nutrition via biomarker input) is directly comparable to Caligenix Biotype, although Caligenix extends into skincare and feedback-loops where Habit did not.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/caligenix
• Instagraminstagram.com/caligenix
• Xx.com/caligenix
• Facebookfacebook.com/caligenix

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Caligenix